Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
- PMID: 22891207
- PMCID: PMC3470615
- DOI: 10.1503/cmaj.121270
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
Comment on
-
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13. CMAJ. 2012. PMID: 22891208 Free PMC article.
Similar articles
-
[Moxifloxacin and hepatic toxicity].Gastroenterol Hepatol. 2009 Dec;32(10):719-20. doi: 10.1016/j.gastrohep.2009.06.004. Epub 2009 Aug 6. Gastroenterol Hepatol. 2009. PMID: 19664854 Spanish. No abstract available.
-
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13. CMAJ. 2012. PMID: 22891208 Free PMC article.
-
Recurrent episodes of hypoglycemia induced by moxifloxacin.Indian J Pharmacol. 2013 May-Jun;45(3):301-2. doi: 10.4103/0253-7613.111908. Indian J Pharmacol. 2013. PMID: 23833380 Free PMC article.
-
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.Curr Med Res Opin. 2007 Jun;23(6):1403-13. doi: 10.1185/030079907X188099. Epub 2007 May 8. Curr Med Res Opin. 2007. PMID: 17559736 Review.
-
Arrhythmias associated with fluoroquinolone therapy.Int J Antimicrob Agents. 2007 Apr;29(4):374-9. doi: 10.1016/j.ijantimicag.2006.11.011. Epub 2007 Jan 22. Int J Antimicrob Agents. 2007. PMID: 17241772 Review.
Cited by
-
Safety of Delafloxacin: Focus on Adverse Events of Special Interest.Open Forum Infect Dis. 2018 Sep 10;5(10):ofy220. doi: 10.1093/ofid/ofy220. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30349845 Free PMC article.
References
-
- Björnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006;38:33–8 - PubMed
-
- Motola D, Vargiu A, Leone R, et al. Hepatic adverse drug reactions: a case–noncase study in Italy. Eur J Clin Pharmacol 2007; 63:73–9 - PubMed
-
- Van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009;32:359–78 - PubMed
-
- Brinker AD, Wassel RT, Lyndly J, et al. Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases. Hepatology 2009;49:250–7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical